A prospective study of (18)FDG PET in the prediction of relapse in patients with high risk clinical stage I (CS1) non-seminomatous germ cell cancer (NSGCT): MRC study TE22


Huddart, R., O'Doherty, M., Padhani, A., Rustin, G., Mead, G., Joffe, J.K., Vasey, P., Hain, S., Kirk, S.J. and Stenning, S.P. (2006) A prospective study of (18)FDG PET in the prediction of relapse in patients with high risk clinical stage I (CS1) non-seminomatous germ cell cancer (NSGCT): MRC study TE22. Journal of Clinical Oncology, 24, (18)

Download

Full text not available from this repository.

Item Type: Article
ISSNs: 0732-183X (print)
Related URLs:
Subjects: R Medicine
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: University Structure - Pre August 2011 > School of Medicine
Item ID: 62792
Date Deposited: 10 Mar 2009
Last Modified: 01 Jun 2011 02:48
Contributors: Huddart, R. (Author)
O'Doherty, M. (Author)
Padhani, A. (Author)
Rustin, G. (Author)
Mead, G. (Author)
Joffe, J.K. (Author)
Vasey, P. (Author)
Hain, S. (Author)
Kirk, S.J. (Author)
Stenning, S.P. (Author)
Date: 20 June 2006
Status: Published
Contact Email Address: gmm1@soton.ac.uk
URI: http://eprints.soton.ac.uk/id/eprint/62792

Actions (login required)

View Item View Item